Christensella: the key to unlocking gut microbiome-based drug discovery?

How will the recall of API valsartan impact patients and the industry?

Why has the stock of pink Migraleve tablets disappeared from UK shelves?

Amanda Feilding'smost urgent policy issues yet to be addressed in the UK

The EMA is lowering the flag of its London base and moving to the Netherlands

Seperating the fact from fiction surrounding pharmaceutical CBD

The case for and against establishing a nationalised drug company in the UK

Research suggests that cancer cells can communicate further that we thought

Patients in the UK are banding together to access a costly cystic fibrosis treatment

Pharma is starting to move away from animal testing in favour of alternative options

Researchers have found a way to improve stability when attaching drugs to antibodies